stockrowArrowhead Pharmaceuticals, Inc. (ARWR) vs Krystal Biotech, Inc. (KRYS)
- Arrowhead Pharmaceuticals, Inc. ARWR 58.19 +1.27%
- Krystal Biotech, Inc. KRYS 304.20 +1.32%
Arrowhead Pharmaceuticals, Inc. and Krystal Biotech, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Krystal Biotech, Inc. are of similar size ($8.9B and $8.1B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 26.0% against 16.1%. Krystal Biotech, Inc. has the higher net margin (47.9% vs −47.8%) and the higher return on invested capital (27.2% vs 0.00%). Across the 17 metrics below, Krystal Biotech, Inc. leads on 13 and Arrowhead Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ARWR | KRYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 94.27% | 65.16% |
| Operating margin | (33.82%) | 48.41% | 0.00% |
| Net margin | (47.79%) | 47.91% | 0.00% |
| Free cash flow margin | (11.22%) | 65.97% | 0.00% |
| Return on equity | (64.91%) | 17.50% | (50.12%) |
| Return on assets | (18.32%) | 15.93% | (45.60%) |
| Return on invested capital | 0.00% | 27.15% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack